Pacific Bio (PACB) Misses Q4 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q4 EPS of ($0.30), $0.02 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $36 million versus the consensus estimate of $36.12 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79